Dr. Roger A Morris, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 933 Elida Ave, Delphos, OH 45833 Phone: 419-692-9050 Fax: 419-692-9060 |
Danielle Mangas, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 933 Elida Ave, Delphos, OH 45833 Phone: 419-692-9050 Fax: 419-692-9060 |
Morris Chiropractic Clinic, Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 933 Elida Ave, Delphos, OH 45891 Phone: 419-692-9050 Fax: 419-692-9060 |
Dr. Thomas R Morris, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 933 Elida Ave, Delphos, OH 45833 Phone: 419-692-9050 Fax: 419-692-9060 |
Dr. Jay Michael Dewitt, D.C Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 333 North St, Delphos, OH 45833 Phone: 419-692-2225 Fax: 419-695-7325 |
News Archive
Romping clumps of misfolded proteins are prime suspects in many neurological disorders including Alzheimer's, Parkinson's, and Creutzfeld-Jakob Disease. Those diseases are devastating and incurable, but a team of biologists at Brown University reports that cells can fix the problems themselves with only a little bit of help. The insight suggests that there are more opportunities to develop a therapy for protein misfolding than scientists had thought.
Veterans of the Iraq/Afghanistan wars showed a 50 percent reduction in their symptoms of post-traumatic stress disorder (PTSD) after just eight weeks of practicing the stress-reducing Transcendental Meditation technique, according to a pilot study published in the June 2011 issue of Military Medicine.
Researchers at The University of Texas M. D. Anderson Cancer Center have figured out a key molecular step by which a cancer cell can unhook itself from the mesh weave of other cancer cells in a tumor, and move away to a different part of the body - the process, known as metastasis, that makes cancer so dangerous.
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
› Verified 6 days ago